Catalent To Expand Clinical Supply Facility in Singapore
By

Catalent Pharma Solutions plans to invest $4.6 million to further expand its Singapore clinical supply facility by building new flexible GMP space for secondary packaging, doubling its ambient storage space, and quadrupling cold-storage capacity. The continued expansion of the site will support global and regional customers' growth in clinical trials activity in the Asia–Pacific region.

Established in 1998, Catalent's Singapore site now provides full clinical supply services including project and supply chain management, comparator sourcing, clinical label printing, secondary packaging, clinical storage, import/export management, importer of record (IoR) service, and full returns and destruction management services. It has served as a regional hub for studies in Australia, Singapore, Korea, Hong Kong,and other countries in Southeast Asia.

Catalent’s clinical supply services has facilities in the US, UK, Germany, Japan, and China.

Source: Catalent Pharma Solutions

Leave a Reply

Your email address will not be published. Required fields are marked *